All Companies
Ticker CRIS
We can't analyze this yet — its market data looks wrong
You reached the page — here's exactly what CRIS is, and why it's out of scope for now.
What this ticker is
CRIS
Curis Inc.
NASDAQ
Healthcare
Biotechnology
Why we can't analyze it yet
Data provider – reported cap ($4,502,037) is 14.5× off vs SEC filings (38,978,693 shares × $1.67 ≈ $65,094,417); source data unreliable
Delvantic analyzes regular securities of single operating companies — one business with revenue, earnings and cash flows our valuation methods can assess bottom-up.
Reason code:
data_corrupt